Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Drops
Sublingual immunotherapy
atopic dermatitis
clinical phase II trial
Journal
Artificial cells, nanomedicine, and biotechnology
ISSN: 2169-141X
Titre abrégé: Artif Cells Nanomed Biotechnol
Pays: England
ID NLM: 101594777
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
23
8
2019
pubmed:
23
8
2019
medline:
14
1
2020
Statut:
ppublish
Résumé
Allergen-specific immunotherapy is widely used for allergic rhinitis and asthma treatment worldwide. This study explored the efficacy and safety of sublingual immunotherapy (SLIT) with the extracts of
Identifiants
pubmed: 31437010
doi: 10.1080/21691401.2019.1640709
doi:
Substances chimiques
Placebos
0
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM